R
Radiopharm Theranostics Ltd
ASX:RAD
Radiopharm Theranostics Ltd
ASX:RAD
Price:
0.022
AUD
-4.35%
Market Closed
Market Cap:
AU$61.2m
Cash Flow Statement
Cash Flow Statement
Radiopharm Theranostics Ltd
Radiopharm Theranostics Ltd
Currency: AUD
| Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||
| Stock-Based Compensation |
3
|
3
|
3
|
2
|
2
|
|
| Change in Working Capital |
2
|
7
|
5
|
0
|
1
|
|
| Cash from Operating Activities |
(23)
N/A
|
(23)
+1%
|
(23)
0%
|
(33)
-45%
|
(37)
-10%
|
|
| Investing Cash Flow | ||||||
| Capital Expenditures |
(2)
|
(1)
|
0
|
0
|
0
|
|
| Other Items |
0
|
0
|
0
|
3
|
2
|
|
| Cash from Investing Activities |
(2)
N/A
|
(1)
+5%
|
0
N/A
|
3
N/A
|
2
-41%
|
|
| Financing Cash Flow | ||||||
| Net Issuance of Common Stock |
10
|
2
|
30
|
73
|
54
|
|
| Net Issuance of Debt |
0
|
0
|
2
|
0
|
(2)
|
|
| Other |
(1)
|
(0)
|
(2)
|
(9)
|
(7)
|
|
| Cash from Financing Activities |
9
N/A
|
2
-79%
|
30
+1 424%
|
65
+116%
|
45
-30%
|
|
| Change in Cash | ||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
(0)
|
0
|
(0)
|
|
| Net Change in Cash |
(15)
N/A
|
(22)
-46%
|
7
N/A
|
35
+402%
|
11
-69%
|
|
| Free Cash Flow | ||||||
| Free Cash Flow |
(25)
N/A
|
(24)
+1%
|
(23)
+6%
|
(33)
-45%
|
(37)
-10%
|
|
Switch to:
Switch to:
See Also
Discover More
